AMENDMENT NO. 1 TO FOUNDER COMMON STOCK PURCHASE AGREEMENTFounder Common Stock Purchase Agreement • June 12th, 2015 • Viking Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledJune 12th, 2015 Company Industry JurisdictionThis Amendment No. 1 to Founder Common Stock Purchase Agreement (this “Amendment”) is made as of May 4, 2015, by and between Viking Therapeutics, Inc., a Delaware corporation (the “Company”), and Brian Lian, Ph.D. (“Purchaser”).
AMENDMENT NO. 1 TO FOUNDER COMMON STOCK PURCHASE AGREEMENTFounder Common Stock Purchase Agreement • June 12th, 2015 • Viking Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledJune 12th, 2015 Company Industry JurisdictionThis Amendment No. 1 to Founder Common Stock Purchase Agreement (this “Amendment”) is made as of May 4, 2015, by and between Viking Therapeutics, Inc., a Delaware corporation (the “Company”), and Michael Dinerman, M.D. (“Purchaser”).